Social Determinants of Health and Cardiologist Involvement in the Care of Adults Hospitalized for Heart Failure

David T Zhang1, Chukwuma Onyebeke1, Musarrat Nahid1

  • 1Department of Medicine, Weill Cornell Medicine, New York, New York.

JAMA Network Open
|November 20, 2023
PubMed

Insights

Low income is linked to less cardiologist involvement for heart failure patients. Socioeconomic status may impact care quality during hospitalizations for heart failure (HF).

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Cardiologist involvement in heart failure (HF) hospitalizations reduces mortality and readmissions.
  • Not all HF patients receive care from a cardiologist during hospitalization.
  • Social determinants of health (SDOH) may influence access to specialist care.

Purpose of the Study:

  • To investigate the association between SDOH and cardiologist involvement in adults hospitalized for HF.
  • To identify specific SDOH factors impacting specialist care access for HF patients.

Main Methods:

  • Retrospective cohort study using the Reasons for Geographic and Racial Difference in Stroke (REGARDS) cohort.
  • Examined 9 SDOH indicators including income, race, education, and location.
  • Used Poisson regression to analyze associations between SDOH and cardiologist involvement.

Main Results:

  • Low annual household income (<$35,000) was significantly associated with reduced cardiologist involvement.
  • Multivariable analysis confirmed an inverse relationship between low income and cardiologist involvement (RR, 0.89; 95% CI, 0.82-0.97).
  • No other tested SDOH showed a statistically significant association with cardiologist involvement.

Conclusions:

  • Adults with low income were 11% less likely to have cardiologist involvement during HF hospitalization.
  • Findings suggest socioeconomic status may introduce bias in HF patient care.
  • Addressing income disparities is crucial for equitable specialist care in HF management.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Heart Failure Drugs: &#946;-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
344
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
398